Journal of Regenerative MedicineISSN: 2325-9620

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Gorka Orive Author

Subjects of specialization
Micro/Nanotecnologies, Drug Delivery, Biomaterials, Biomarkers, Regenerative Medicine

Affiliation
Faculty of Pharmacy, Laboratory of Pharmacy and Pharmaceutical Technology, University of the Basque Country, Vitoria Gasteiz, Spain

Biography

Gorka holds a Bachelor degree in Pharmacy and his PhD from the University of the Basque Country (Vitoria, Spain). He is Associate Professor in Pharmacy at the University of the Basque Country. He is founder of GEROA DIAGNOSTICS, a biotechnological company whose mission is to improve the health, the life-quality and medical care of patients suffering from Alzheimer’s disease.


Publications

Letter to Editor Open Access

Platelet-Rich Plasma Therapies:In the Right Pathway to Find their Regulatory Niche

Author(s):

Eduardo Anitua, Roberto Prado1 and Gorka Orive

Platelet-Rich Plasma Therapies:In the Right Pathway to Find their Regulatory Niche

The Spanish Agency of Medicines and Medical Devices (AEMPS) has recently regulated the use of platelet-rich plasma (PRP), that is,patient’s own plasma enriched in platelets and therefore in proteins and growth factors, as a human use drug. It is the first time that one regulatory agency worldwide categorizes these types of therapeutic therapies. According to AEMPS, PRP approaches cannot be considered as an advanced-therapy medicinal product. PRPs are classified as non-industrial biological medicines, being subjected to a strict regulation in terms of production, validation, efficacy an... view moreĀ»

DOI: 10.4172/2325-9620.1000112

Abstract HTML PDF



Social Media


Google Scholars / Researchers Sites

GET THE APP